8-27811070-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_018492.4(PBK):āc.660G>Cā(p.Glu220Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00368 in 1,613,190 control chromosomes in the GnomAD database, including 201 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_018492.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0192 AC: 2920AN: 152198Hom.: 104 Cov.: 32
GnomAD3 exomes AF: 0.00517 AC: 1299AN: 251350Hom.: 52 AF XY: 0.00373 AC XY: 507AN XY: 135830
GnomAD4 exome AF: 0.00206 AC: 3006AN: 1460874Hom.: 97 Cov.: 30 AF XY: 0.00176 AC XY: 1276AN XY: 726790
GnomAD4 genome AF: 0.0192 AC: 2928AN: 152316Hom.: 104 Cov.: 32 AF XY: 0.0183 AC XY: 1365AN XY: 74480
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 24, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at